Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Deferred Taxes (2023)

Perspective Therapeutics (CATX) has disclosed Deferred Taxes for 1 consecutive years, with $7.8 million as the latest value for Q4 2023.

  • Quarterly Deferred Taxes changed N/A to $7.8 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Sep 2024, up 174.75% year-over-year, with the annual reading at -$420000.0 for FY2025, N/A changed from the prior year.
  • Deferred Taxes hit $7.8 million in Q4 2023 for Perspective Therapeutics, up from -$10.5 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $7.8 million in Q4 2023 to a low of -$10.5 million in Q1 2023.